Opendata, web and dolomites

Horizon2020 projects coordinated by "INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE"

# project acronym  year  total cost  totalcontribution 
1 REACTION Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans 2014 2˙755˙719.00 2˙575˙809.00
2 EBOVAC2 Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II - Sofia ref.: 115861 2014 50˙710˙893.00 22˙790˙820.00
3 CANNAPREG Development of pregnenolone derivatives as allosteric inhibitors of CB1 cannabinoid receptors for the treatment of schizophrenia and psychotic syndromes 2015 150˙000.00 150˙000.00
4 JPCO-FUND ERA-NET for establishing synergies between the Joint Programming on Neurodegenerative Diseases Research and Horizon 2020 2015 30˙953˙030.00 9˙999˙999.00
5 CORTICALS Amyotrophic Lateral Sclerosis from a cortical perspective: towards alternative therapeutic strategies 2015 1˙500˙000.00 1˙500˙000.00
6 GABACODEV Role of GABAergic microcircuits with different embryonic origins in the orchestration of early cortical dynamics in the awake mouse pup 2015 173˙076.00 173˙076.00
7 CHAT Control of the Homeostasis of Actin through Time: actin homeostasis during embryonic development by means of single-molecule imaging and simulation in C. elegans 2015 185˙076.00 185˙076.00
8 CLOPRESS Renal Chloride Chanels and Blood Pressure Regulation 2015 173˙076.00 173˙076.00
9 COMPUCELL Autonomous Cellular Computers for Diagnosis 2015 1˙500˙000.00 1˙500˙000.00
10 RISTRAD Risk Stratification for Sudden Cardiac Death 2015 173˙076.00 173˙076.00
11 ENSAT-HT Application of omics-based strategies for improved diagnosis and treatment of endocrine hypertension 2015 8˙440˙635.00 7˙607˙337.00
12 ADIPOR Molecular and structural pharmacology of adiponectin receptor: towards innovative treatments of obesity-related diseases. 2015 1˙989˙518.00 1˙989˙518.00
13 MOBILISENSE Air pollution and noise exposure related to personal transport behaviour: short-term and longer-term effects on health 2015 2˙000˙000.00 2˙000˙000.00
14 ID4 Role of Id4 in the adult subventricular zone of normal and injured brain 2015 173˙076.00 173˙076.00
15 BRAIN MICRO SNOOPER A mimetic implant for low perturbation, stable stimulation and recording of neural units inside the brain. 2015 1˙499˙850.00 1˙499˙850.00
16 SHIPS Screening to improve Health In very Preterm infantS in Europe 2015 2˙993˙175.00 2˙993˙174.00
17 CHEMREPEAT Structure and Dynamics of Low-Complexity Regions in Proteins: The Huntingtin Case 2015 1˙999˙844.00 1˙999˙844.00
18 ALLERGYBLOCK Blocking peanut allergy through protective IgG antibodies 2015 185˙076.00 185˙076.00
19 ACTINIT Brain-behavior forecasting: The causal determinants of spontaneous self-initiated action in the study of volition and the development of asynchronous brain-computer interfaces. 2015 1˙338˙130.00 1˙338˙130.00
20 NEURIMMUNE Neural regulation of immunity 2015 2˙000˙000.00 2˙000˙000.00
21 NEUROPIONEERS A developmental engram for the organization of adult hippocampal circuits 2015 1˙996˙947.00 1˙996˙947.00
22 TANYFEEDNEURONS Gliotransmission and shuttling of metabolic signals to feeding neuronal circuits by tanycytes 2015 185˙076.00 185˙076.00
23 ELASTOCARDIOSCOPE An innovative tool for non-invasive evaluation of myocardial stiffness 2015 149˙750.00 149˙750.00
24 JPSUSTAIND Coordination Action in support of the sustainability and globalisation of the Joint Programming Initiative on Neurodegenerative Diseases 2015 2˙043˙283.00 2˙043˙283.00
25 LYMPHOSIGN Integrated study of the role of B-cell receptor signaling in the development of Follicular Lymphoma 2015 200˙119.00 200˙119.00
26 EDEN Ependymal cell Development: New insight into neurological diseases 2015 1˙999˙484.00 1˙999˙484.00
27 ERINHA2 European Research Infrastructure on Highly Pathogenic Agents 2 2016 1˙443˙927.00 1˙443˙927.00
28 HEPCIR Cell circuits as targets and biomarkers for liver disease and cancer prevention 2016 2˙305˙000.00 2˙305˙000.00
29 MECHANOFATE From mechanical stress to vascular fate 2016 1˙498˙412.00 1˙498˙412.00
30 PRETREAT PRoteome-based assessment of vascular disease for the Establishment of a Translational REsearch plATform 2016 387˙000.00 387˙000.00
31 MEDIT-AGEING Investigating the impact of meditation training on mental health and wellbeing in the ageing population 2016 7˙087˙230.00 6˙134˙756.00
32 SAFEIMMUNOSUPPRESS Development of immunosuppressive treatments with better safety 2016 150˙000.00 150˙000.00
33 EHVA European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates 2016 28˙135˙596.00 22˙188˙521.00
34 PREG-LAB Distinctive characterization of regulatory plasma cells and pro-inflammatory B cells in immunity: their origins, molecular properties, and cellular fates. 2016 1˙999˙375.00 1˙999˙375.00
35 MINERVA Micro-RNAs of neutrophils in renal ANCA-associated vasculitis 2016 173˙076.00 173˙076.00
36 OPTONMDA Optical strategies to investigate NMDA receptor functional diversity and its therapeutic potential 2016 185˙076.00 185˙076.00
37 ICARO Ion Channels and Receptors Operation 2016 173˙076.00 173˙076.00
38 CD4DNASP Cell intrinsic control of CD4 T cell differentiation by cytosolic DNA sensing pathways 2016 1˙500˙000.00 1˙500˙000.00
39 ILC_REACTIVITY Biological Determinants of ILC Reactivity for Immune Responses in Health and Disease 2016 1˙899˙375.00 1˙899˙375.00
40 COBABATI Cofactor Binding Antibodies – Basic Aspects and Therapeutic Innovations 2016 1˙255˙000.00 1˙255˙000.00
41 B-RESPONSE Memory and innate-like B-cell subsets: deciphering a multi-layered B-cell response in mice and humans 2016 2˙098˙750.00 2˙098˙750.00
42 SEMA3C Genetic dissection of the SEMA3C/Neuropilin 1 signalling pathway in Chronic Kidney Disease progression 2016 185˙076.00 185˙076.00
43 PTOACONS Going from Phenomenal to Access Consciousness: Neurobehavioural correlates of visual consciousness development and its underlying cognitive procesess. 2016 173˙076.00 173˙076.00
44 ZIKALLIANCE A global alliance for Zika virus control and prevention 2016 15˙684˙925.00 11˙964˙209.00
45 EPITOR NEUROBIOLOGY OF EPILEPSY GENES 2016 1˙998˙760.00 1˙998˙760.00
46 GENE FOR CURE Expanding and extending gene therapy of monogenic diseases of the haematopoietic system 2016 2˙445˙267.00 2˙445˙267.00
47 NMDADYN NMDA receptor diversity: from molecular dynamics to synaptic physiopathology 2016 2˙500˙000.00 2˙500˙000.00
48 MIDOC Multimodal Imaging of Disorders of Consciousness 2016 185˙076.00 185˙076.00
49 PANDORA Platelets: at the nexus of brain aneurysm 2016 173˙076.00 173˙076.00
50 DYNAMATT Dynamics of Attentional Networks in the Human Brain in Health and Disease: Evidence from Intracerebral and MEG Recordings 2017 185˙076.00 185˙076.00
51 VITRUVIUS The Genetics and Physiology of Growth and Size Determination 2017 2˙499˙144.00 2˙499˙144.00
52 BRAINDYN Tracking information flow in the brain: A unified and general framework for dynamic communication in brain networks 2017 1˙333˙718.00 1˙333˙718.00
53 ROSALIND Investigating fibROmuscular dysplasia and spontaneous coronary Artery dissection using genetic and functionaL genomics to decipher the origIN of two female specific cardiovascular Diseases 2017 1˙500˙000.00 1˙500˙000.00
54 INSTANTSCOPE Development of high-resolution, high-throughput microscopy 2017 149˙788.00 149˙788.00
55 PARAGEN Biomaterials with incorporated MSC-secreted PARAcrine molecules for bone reGENeration 2017 246˙668.00 246˙668.00
56 ALS-NETWORKS Defining functional networks of genetic causes for ALS and related neurodegenerative disorders 2017 2˙000˙000.00 2˙000˙000.00
57 PROGLUTASIS Protection of cardiometabolic inflammation by modulation of myeloid glutamine homeostasis 2017 2˙091˙338.00 2˙091˙338.00
58 REG-SEQ Functional genomics of non-coding mutations in regulatory regions of four metabolic tissues, and their involvement into type 2 diabetes through large-scale sequencing 2017 1˙500˙000.00 1˙500˙000.00
59 REPRODAMH Extra-gonadal roles of Anti-Müllerian Hormone in the aetiology of polycystic ovary syndrome: the domino effect to reproductive neuroendocrine dysfunctions 2017 1˙999˙740.00 1˙999˙740.00
60 NANOVOLTSENS Voltage-sensing nanorods for super-resolution voltage imaging in neurons 2017 185˙076.00 185˙076.00
61 INVESTIGERFE Investigating the regulation of iron homeostasis by erythroferrone and therapeutic applications 2017 1˙499˙235.00 1˙499˙235.00
62 SPONTANEOUS ZEBRAIN Whole-brain dynamics underlying self-generated behaviour 2017 1˙997˙360.00 1˙997˙360.00
63 PRELICAN Treatment of liver disease and cancer prevention 2017 150˙000.00 150˙000.00
64 CETACEAN INNER EAR Cetacean Inner Ear 2017 185˙076.00 185˙076.00
65 NASCENTOMIX Ribosome inhibition by nascent or antimicrobial peptides 2017 1˙999˙125.00 1˙999˙125.00
66 EPIFAT Epigenomic Reprogramming of Adipose Tissue Function and Energy Metabolism in Type 2 Diabetes 2017 2˙000˙000.00 2˙000˙000.00
67 METACHROM Establishment and maintenance of gene expression by heterochromatin factors 2017 1˙999˙025.00 1˙999˙025.00
68 NEUCOSE The neural correlates of the self in altered states of consciousness. 2017 185˙076.00 185˙076.00
69 NEMESIS Neuron/mast cell interactions in skin diseases 2017 185˙076.00 185˙076.00
70 DISTRICT DECIPHERING THE ROLE OF TRIB1 IN REGULATORY T CELLS 2017 185˙076.00 185˙076.00
71 ANTIVIR Molecular mechanisms of interferon-induced antiviral restriction and signalling 2017 1˙499˙793.00 1˙499˙793.00
72 R-LINK Optimizing response to Li treatment through personalized evaluation of individuals with bipolar I disorder: the R-LiNK initiative 2018 7˙808˙072.00 7˙702˙532.00
73 MAXIBONE Personalised maxillofacial bone regeneration 2018 5˙975˙915.00 5˙949˙665.00
74 RONDBIOCAN NLRP3 in cancer: Deciphering the role of NLRP3 in the DNA Damage response pathway 2018 173˙076.00 173˙076.00
75 TRANSTRYP Structural differences in mRNA translation machineries between eukaryotic pathogens and their mammalian hosts 2018 1˙787˙400.00 1˙787˙400.00
76 EU-TRAIN The EUropean TRAnsplantation and INnovation (EU-TRAIN) consortium for improving diagnosis and risk stratification in kidney transplant patients 2018 6˙641˙546.00 6˙641˙546.00
77 ENLIGHTEN INTEGRATION AND PROPAGATION OF IMMUNOLOGICAL SIGNALS DURING CANCER AND INFECTION 2018 2˙499˙994.00 2˙499˙994.00
78 BRAVEST Boosting Reward-based Attention through VEstibular STimulation 2018 173˙076.00 173˙076.00
79 DRIVE GUIDANCE AND FUNCTION OF REGENERATIVE FIBERS IN ADULT CNS 2018 1˙499˙410.00 1˙499˙410.00
80 ALTCHEM In vivo functional screens to decipher mechanisms of stochastically- and mutationally-induced chemoresistance in Acute Myeloid Leukemia 2018 1˙500˙000.00 1˙500˙000.00
81 SYNPCP Synapse formation and maturity through planar cell polarity pathway 2018 173˙076.00 173˙076.00
82 NEUROREMOD Mechanisms of neuronal network remodeling in the adult mammalian brain 2018 1˙493˙750.00 1˙493˙750.00
83 EXCITATOR Active probing of brain excitability by electrical micro-stimulations for drug discovery 2018 150˙000.00 150˙000.00
84 IMMUNAID Immunome project consortium for AutoInflammatory Disorders 2018 15˙835˙851.00 15˙835˙851.00
85 OPTIMIZERR Errors as cost-optimizing decisions? Redefining the origin and nature of human decision errors in light of associated neural computations 2018 1˙497˙125.00 1˙497˙125.00
86 CXCR4THERAPY IMPROVING HEMATOPOIETIC STEM CELL- BASED GENE THERAPY OUTCOME BY MODULATING CXCR4 EXPRESSION 2018 173˙076.00 173˙076.00
87 CROWDASSAY Folding Pathways of DNA G-quadruplexes in Crowding Conditions, and Implications for Mass Spectrometry-based Ligand Screening Assays 2018 173˙076.00 173˙076.00
88 DAMOCLES Modelling brain aneurysm to elucidate the role of platelets 2018 1˙498˙618.00 1˙498˙618.00
89 PBIOSTRAT-FOR-PDA Use of PAP as a biomarker and stratifier of pancreatic cancer to improve patient management 2018 150˙000.00 150˙000.00
90 STARNEL supracellular contractility of myofibroblasts in gut homeostasis and cancer invasion 2018 2˙000˙000.00 2˙000˙000.00
91 HUMAN TEXTILES Human, Woven, Tissue-Engineered Blood Vessels (TEBV) Exclusively from Cell-Assembled Extracellular Matrix (CAM). 2018 2˙491˙543.00 2˙491˙543.00
92 MICABRA Mitochondrial Cannabinoid Receptors in the Brain 2018 2˙500˙000.00 2˙500˙000.00
93 EXOGENESIS Syntenin-phosphatidic acid interaction in exosome biogenesis and cell-cell communication: a structure-function based approach 2018 173˙076.00 173˙076.00
94 OBERON An integrative strategy of testing systems for identification of EDs related to metabolic disorders 2019 6˙745˙894.00 5˙978˙762.00
95 JPCOFUND2 ERA-NET to support the Joint Programming in Neurodegenerative Diseases strategic plan (JPND) 2019 33˙438˙899.00 11˙010˙911.00
96 EJP RD European Joint Programme on Rare Diseases 2019 100˙176˙062.00 55˙073˙831.00
97 IMMCEPTION Nociception and sensory nerves as regulators of type 2 immunity and skin inflammation 2019 1˙497˙441.00 1˙497˙441.00
98 RIBOINFLAM Assessing the role of ribosomes and mRNA translation in shaping the inflammatory response 2019 1˙499˙720.00 1˙499˙720.00
99 HERA Integrating Environment and Health Research: a Vision for the EU 2019 3˙097˙322.00 3˙097˙322.00
100 GABASSEMBLY The role of GABAergic circuits in the orchestration of hippocampal neuronal assemblies 2019 173˙076.00 173˙076.00
101 NECESSITY NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients 2019 15˙425˙020.00 8˙200˙000.00
102 EFHHBBBMS Endothelial Hedgehog autocrine signaling at the Blood Brain Barrier controls inflammatory CentralNervous System lesion size and severity through Gas1 co-receptor modulation. 2019 173˙076.00 173˙076.00
103 WATCH Well-Aging and the Tanycytic Control of Health 2019 9˙866˙250.00 9˙866˙250.00
104 CARDIATEAM CARdiomyopathy in type 2 DIAbetes mellitus 2019 12˙882˙500.00 6˙700˙000.00
105 LUNG-BIM Induction of B cell immunity in the lung mucosa 2019 184˙707.00 184˙707.00
106 PML-THERAPY HARNESSING PML NUCLEAR BODIES FOR LEUKAEMIA THERAPY 2019 2˙500˙000.00 2˙500˙000.00
107 MECHANOMVP Mechanosensing and Mitral Valve Prolapse: from the Molecular Mechanisms to the Progression of the Disease 2019 196˙707.00 196˙707.00
108 SYNPATH Regulation of synaptic development and plasticity by molecular pathways linked to human evolution 2019 1˙500˙000.00 1˙500˙000.00
109 BREAKINGBARRIERS Targeting endothelial barriers to combat disease 2019 2˙499˙969.00 2˙499˙969.00
110 AB-DIRECT Antibiotic Distribution and Recovery in Tissue 2019 3˙789˙717.00 3˙429˙217.00
111 ADMEHE Mental health advocacy: Reassessing the history of mental health organizations in the second half of the twentieth century 2019 185˙076.00 185˙076.00
112 REMAKIN REstoring myocardial repair capacity via the modulation of MAcrophage-mediated cytoKINe secretion. 2019 196˙707.00 196˙707.00
113 STOPIG Translating fundamental insights in podocyte metabolism and cell cycle regulation: development of a new treatment for Stopping crescentic Immune Glomerulonephritis 2019 150˙000.00 150˙000.00
114 LABRHYTHMS Language and Brain Rhythms 2019 184˙707.00 184˙707.00
115 INVADERS Mucus-Penetrating Microbiota: Characterization, Mechanism and Therapeutic in Metabolic Disease 2019 1˙850˙000.00 1˙850˙000.00
116 HEPCAN A Humanized Monoclonal Anti-Claudin1 Antibody (anti-CLDN1 mAb) for Treatment of Hepatocellular Carcinoma (HCC) 2019 0.00 150˙000.00
117 MIR-IBD Fecal miRNAs, new mediators of host-microbiota interaction in Inflammatory Bowel Disease 2019 196˙707.00 196˙707.00
118 METABOSENS Metabolic integration by nutrient SENSing 2019 1˙999˙391.00 1˙999˙391.00
119 IP-CURE-B Immune profiling to guide host-directed interventions to cure HBV infections 2020 14˙943˙030.00 9˙983˙029.00
120 FAIR FLAGELLIN AEROSOL THERAPY AS AN IMMUNOMODULATORY ADJUNCT TO THE ANTIBIOTIC TREATMENT OF DRUG-RESISTANT BACTERIAL PNEUMONIA 2020 10˙162˙903.00 10˙162˙903.00
121 PREMSTEM Brain injury in the premature born infant: stem cell regeneration research network 2020 10˙708˙285.00 8˙999˙620.00
122 MININO Associative mechanisms linking a defective minipuberty to the appearance of mental and nonmental disorders: infantile NO replenishment as a new therapeutic possibility 2020 6˙487˙770.00 6˙487˙770.00
123 HUGODECA Human Gonad Developmental Cell Atlas 2020 4˙822˙198.00 4˙822˙197.00
124 THERALYMPH Gene Therapy to restore lymphatic flow lymphedema 2020 8˙064˙946.00 8˙064˙946.00
125 REMEDIA Impact of exposome on the course of lung diseases 2020 11˙134˙616.00 11˙134˙616.00
126 SUMIDENTITY Deconstructing the role of SUMO on chromatin in cell identity and tissue repair 2020 2˙499˙995.00 2˙499˙995.00
127 ENHPATHY Molecular basis of human enhanceropathies 2020 3˙992˙397.00 3˙992˙397.00
128 FLUATTACK Validation of a novel antiviral drug candidate against influenza 2020 0.00 150˙000.00
129 METEPIC P53-dependent Metabolic and Epigenetic Reprogramming in Carcinogenesis 2020 196˙707.00 196˙707.00
130 EVOMENS The evolution of menstruation in primates 2020 1˙185˙250.00 1˙185˙250.00
131 EDUC8 Early Stage Researchers EDUCational Program on Factor VIII Immunogenicity 2020 2˙100˙708.00 2˙100˙708.00
132 EVEREST Extracellular Vesicles for Bone Regeneration – alternatives to Stem-cell Therapy 2020 1˙499˙925.00 1˙499˙925.00
133 ADDITIVES Exposure to ‘cocktails’ of food additives and chronic disease risk 2020 2˙000˙000.00 2˙000˙000.00
134 KISSANDSPITRHOPTRY Unravelling the secretion machinery for virulence factors in apicomplexan parasites 2020 2˙496˙210.00 2˙496˙210.00
135 ANTIBIOCLICKS BioInspired Clicked Siderophore-Antibiotics 2020 2˙000˙000.00 2˙000˙000.00
136 PMLINGAML Using PML nuclear body biology to identify potential AML treatment targets 2020 184˙707.00 184˙707.00
137 BICICLE Biophysics of circulating tumor cells, from single molecule to cell clusters 2020 184˙707.00 184˙707.00
138 HT4PD The role of the serotonin 5-HT4 receptor in motor and non-motor symptoms of Parkinson’s disease 2021 295˙061.00 295˙061.00
139 NICHEADAPT Deciphering the niche adaptations of a gut commensal involved in educating the host immune system 2021 1˙999˙948.00 1˙999˙948.00

More Horizon 2020 projects

The Institution INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE has been involved also in the following Horizon 2020 projects.